Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder [NA]

View source ↗

Summary

This clinical trial is evaluating the BTL Emsella chair versus sham for the treatment of overactive bladder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BTL Emsella chair

Snippet

Sponsor: Corewell Health East | Conditions: Overactive Bladder Syndrome, Overactive Bladder | NA | Status: RECRUITING